On his last day in office, New Jersey’s outgoing governor signed bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the psychedelic treatment effort.
Following its passage by the legislature last week, Gov. Phil Murphy (D) signed the measure into law as one of his final acts in office, hours before new Gov. Mikie Sherrill (D) was sworn in.
“Studies conducted by nationally and internationally recognized medical institutions indicate that psilocybin has shown efficacy, tolerability, and safety in the treatment of a variety of behavioral health conditions,” the bill’s findings sections says, “including, but not limited to, substance use disorders, depression, anxiety disorders, and end-of-life psychological distress.”
The legislation, sponsored by Senate President Nick Scutari (D) and Sen. Joseph Vitale (D), along with Assemblymembers Clinton Calabrese (D) and Anthony S. Verrelli (D), will create an 11-member Psychedelic Therapy and Research Advisory Board to oversee the new Psilocybin Behavioral Health Services Pilot Program.
Within 180 days of enactment, the Department of Health will be required to issue a request for proposals from hospitals that want to participate. One hospital from each of three geographic regions of the state will then be selected to receive
Read full article on Marijuana Moment
